BiotechTube
Home/March Biosciences/Sarah Hein, PhD
SH

Sarah Hein, PhD

CEO, Co-Founder

March Biosciences

Therapeutic Areas

OncologyHematological Cancers

March Biosciences Pipeline

DrugIndicationPhase
MB-105CD5+ relapsed or refractory T-cell lymphomas (TCL)Phase 2

Leadership Team at March Biosciences

MM
Maksim Mamonkin, PhD
CSO, Co-Founder
LD
Leah Dimascio, PhD
Chief Operating Officer
AB
Alice Bexon, MD
Acting Chief Medical Officer
MB
Malcolm Brenner, MD, PhD
Co-founder, Chair of Scientific Advisory Board
View full March Biosciences profile